Grimes & Company’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
Grimes & Company's RCKT Position: Q3 2026 in Review
Grimes & Company held its Rocket Pharmaceuticals (RCKT) position steady in Q3 2026 at 12,001 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #461.
Grimes & Company first reported a position in RCKT in Q3 2025 and has held it in 5 quarters since. The position peaked at $50.2K in Q3 2025. 174 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- Grimes & Company held 12,001 shares of Rocket Pharmaceuticals worth $31.6K as of Q3 2026.
- Grimes & Company left its Rocket Pharmaceuticals share count unchanged in Q3 2026.
- Rocket Pharmaceuticals made up ﹤0.01% of Grimes & Company's portfolio in Q3 2026, its #461 holding.
- Grimes & Company first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Grimes & Company's Rocket Pharmaceuticals position peaked at $50.2K in Q3 2025.
- 174 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on Grimes & Company's 13F filing for Q3 2026, filed 29 Oct 2026.